TCV Trust & Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$365K Hold
693
0.03% 168
2026
Q1
$389K Buy
693
+18
+3% +$11.5K 0.03% 162
2025
Q4
$457K Hold
675
0.04% 154
2025
Q3
$431K Sell
675
-25
-4% -$15.2K 0.04% 159
2025
Q2
$375K Hold
700
0.03% 166
2025
Q1
$294K Hold
700
0.03% 168
2024
Q4
$289K Hold
700
0.03% 166
2024
Q3
$354K Sell
700
-4
-0.6% -$1.94K 0.03% 158
2024
Q2
$343K Hold
704
0.03% 158
2024
Q1
$380K Hold
704
0.04% 157
2023
Q4
$391K Hold
704
0.04% 152
2023
Q3
$308K Hold
704
0.03% 155
2023
Q2
$354K Hold
704
0.04% 153
2023
Q1
$352K Hold
704
0.04% 151
2022
Q4
$287K Hold
704
0.03% 165
2022
Q3
$229K Buy
704
+4
+0.6% +$1.47K 0.03% 170
2022
Q2
$246K Hold
700
0.03% 178
2022
Q1
$383K Hold
700
0.04% 160
2021
Q4
$461K Hold
700
0.05% 151
2021
Q3
$435K Hold
700
0.05% 144
2021
Q2
$446K Hold
700
0.05% 140
2021
Q1
$343K Hold
700
0.04% 153
2020
Q4
$350K Hold
700
0.04% 149
2020
Q3
$275K Hold
700
0.04% 156
2020
Q2
$231K Buy
+700
New +$203K 0.03% 165

Other funds holding IDXX

TCV Trust & Wealth Management's IDXX Position: Q2 2026 in Review

TCV Trust & Wealth Management held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 693 shares worth $365K. The position accounts for 0.03% of the portfolio, ranked #168.

TCV Trust & Wealth Management first reported a position in IDXX in Q2 2020 and has held it in 25 quarters since. The position peaked at $461K in Q4 2021. 512 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • TCV Trust & Wealth Management held 693 shares of Idexx Laboratories worth $365K as of Q2 2026.
  • TCV Trust & Wealth Management left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up 0.03% of TCV Trust & Wealth Management's portfolio in Q2 2026, its #168 holding.
  • TCV Trust & Wealth Management first reported a position in Idexx Laboratories in Q2 2020 and has held it in 25 quarters since.
  • TCV Trust & Wealth Management's Idexx Laboratories position peaked at $461K in Q4 2021.
  • 512 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on TCV Trust & Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.